Jean Mathieu Beauregard

Jean Mathieu Beauregard

Université Laval - Québec / Canada
Engineering & Technology / Nuclear Engineering
AD Scientific Index ID: 654220
Laval University
person_outline Jean Mathieu Beauregard's MOST POPULAR ARTICLES
1-) Lutetium-177–PSMA-617 for metastatic castration-resistant prostate cancerO Sartor, J De Bono, KN Chi, K Fizazi, K Herrmann, K Rahbar, ST Tagawa, ...New England Journal of Medicine 385 (12), 1091-1103, 20214792021
2-) Diagnostic Performance of 18F-DCFPyL-PET/CT in Men with Biochemically Recurrent Prostate Cancer: Results from the CONDOR Phase III, Multicenter StudyMJ Morris, SP Rowe, MA Gorin, L Saperstein, F Pouliot, D Josephson, ...Clinical Cancer Research 27 (13), 3674-3682, 20211562021
3-) Quantitative 177Lu SPECT (QSPECT) imaging using a commercially available SPECT/CT systemJM Beauregard, MS Hofman, JM Pereira, P Eu, RJ HicksCancer Imaging 11 (1), 56-66, 20111442011
4-) Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: initial results from the P-PRRT trialM Del Prete, FA Buteau, F Arsenault, N Saighi, LO Bouchard, A Beaulieu, ...European journal of nuclear medicine and molecular imaging 46, 728-742, 20191602019
5-) The tumour sink effect on the biodistribution of 68Ga-DOTA-octreotate: implications for peptide receptor radionuclide therapyJM Beauregard, MS Hofman, G Kong, RJ HicksEuropean journal of nuclear medicine and molecular imaging 39, 50-56, 20121532012